Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin-(1-12) Axis in Hypertension with Lisinopril
NCT05644769Phase 4Unknown
- Sponsor
- Trinity Hypertension & Metabolic Research Institute
- Start
- Nov 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lisinopril in hypertension (HTN), sponsored by Trinity Hypertension & Metabolic Research Institute. Status: unknown.
02
Drugs
lisinopril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05644769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05644769.